Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,360
Closed -$157K 609
2025
Q4
$157K Sell
2,360
-4,506
-66% -$291K 0.01% 1553
2025
Q3
$462K Buy
6,866
+4,481
+188% +$355K 0.03% 840
2025
Q2
$208K Sell
2,385
-4,660
-66% -$365K 0.02% 1103
2025
Q1
$481K Sell
7,045
-1,120
-14% -$91.4K 0.05% 541
2024
Q4
$635K Buy
8,165
+6,621
+429% +$490K 0.08% 382
2024
Q3
$104K Sell
1,544
-2,754
-64% -$226K 0.01% 1277
2024
Q2
$487K Buy
4,298
+3,549
+474% +$449K 0.07% 462
2024
Q1
$104K Buy
+749
New +$94.1K 0.02% 808

Other funds holding DXCM

AlphaQuest's DXCM Position: Q1 2026 in Review

AlphaQuest sold out of DexCom (DXCM) in Q1 2026, closing a stake of 2,360 shares — an estimated $157K sold.

AlphaQuest first reported a position in DXCM in Q1 2024 and held it in 8 quarters. The position peaked at $635K in Q4 2024. 962 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • AlphaQuest reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 2,360 DexCom shares in Q1 2026, an estimated $157K.
  • AlphaQuest first reported a position in DexCom in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's DexCom position peaked at $635K in Q4 2024.
  • 962 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.